IMMUNO-BIOLOGICAL LABORATORIES CO., LTD. · 株式会社免疫生物研究所
Last · Tokyo¥1057.00-31.00 (-2.85%)close · yahoo · 6h ago
Market cap¥9.8B9.3M sh
P/E · TTM26.7fwd — · eps 39.55
Beta-0.06vs S&P 500
Div yield0.68%annual · TTM
52w range
¥464.00¥3820.00
Volume61.0Ksession
| Revenue | ¥1.0B |
|---|---|
| Operating income | ¥281.3M |
| Net income | ¥329.0M |
| Free cash flow | ¥261.0M |
| Operating margin | 28.0% |
| Net margin | 32.7% |
| Return on equity | 17.8% |
| Period | 2026 |
Loading chart…
OpenFilings analyst
Our analyst
From latest ANNUAL · 2021-12-22
- Operating Cf Burn
- Net Margin Sharply Negative
- Cash Runway Medium
- Accumulated Deficit High
- Rd Intensity High
Red flags
- Operating Cf Burn — Negative operating cash flow
- Net Margin Sharply Negative — Net margin -52.9%
- Cash Runway Medium — Cash runway ~2.8 years
- Accumulated Deficit High — Accumulated deficit / equity 212%
- Rd Intensity High — R&D/Revenue 44.3%
Documents
FormReporting forFiledFlags